Cargando…
Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells
Autores principales: | Yang, Qu, Zhang, Shanyong, Kang, Mingyang, Dong, Rongpeng, Zhao, Jianwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317159/ https://www.ncbi.nlm.nih.gov/pubmed/34278510 http://dx.doi.org/10.3892/or.2021.8144 |
Ejemplares similares
-
Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin
por: Qu, Yang, et al.
Publicado: (2022) -
Retraction: Oxymatrine Synergistically Potentiates the Antitumor Effects of Cisplatin in Human Gastric Cancer Cells
por: Liu, Yan, et al.
Publicado: (2021) -
Retraction Notice to: GLP2 Promotes Directed Differentiation from Osteosarcoma Cells to Osteoblasts and Inhibits Growth of Osteosarcoma Cells
por: Lu, Yi, et al.
Publicado: (2022) -
Sorafenib and Doxorubicin Show Synergistic Effects in Human and Canine Osteosarcoma Cell Lines
por: Yang, Ya-Ting, et al.
Publicado: (2022) -
Retracted: MicroRNA‐224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1
Publicado: (2019)